The U.S. Food and Drug Administration mandates that they perform the same way and are as safe and effective as brand–name drugs. However, makers of generics don’t have to repeat the clinical trials done on the originals. To be approved by the FDA, a generic must show “bioequivalence”—there can’t be a significant difference from the brand in the rate and amount of absorption of the drug when...